HealthEquity Management

Management criteria checks 3/4

HealthEquity's CEO is Jon Kessler, appointed in Feb 2014, has a tenure of 10.25 years. total yearly compensation is $13.40M, comprised of 5.2% salary and 94.8% bonuses, including company stock and options. directly owns 0.45% of the company’s shares, worth $31.19M. The average tenure of the management team and the board of directors is 2.8 years and 7.7 years respectively.

Key information

Jon Kessler

Chief executive officer

US$13.4m

Total compensation

CEO salary percentage5.2%
CEO tenure10.3yrs
CEO ownership0.5%
Management average tenure2.8yrs
Board average tenure7.7yrs

Recent management updates

Recent updates

Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

May 03
Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

Apr 11
Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

HealthEquity: Multiple Compression Has Finally Made It A Buy

Mar 21

Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Dec 28
Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Is HealthEquity (NASDAQ:HQY) A Risky Investment?

Nov 17
Is HealthEquity (NASDAQ:HQY) A Risky Investment?

HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price

Oct 26
HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Jul 27
Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 07
HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate

Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Apr 18
Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?

Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Mar 14
Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Dec 24
Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Dec 02
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 11
Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Sep 08
These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M

Sep 06

HealthEquity: Asymmetry In Valuation Continues To Widen

Aug 25

HealthEquity COO steps down, CEO to assume his responsibilities

Aug 02

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Jul 27
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

Jul 06
Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

May 24
These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Apr 12
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

An Intrinsic Calculation For HealthEquity, Inc. (NASDAQ:HQY) Suggests It's 29% Undervalued

Mar 16
An Intrinsic Calculation For HealthEquity, Inc. (NASDAQ:HQY) Suggests It's 29% Undervalued

HealthEquity: Quality Firm, But Not Likely Worth The Price

Mar 01

These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Jan 28
These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Jan 02
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 26% Below Their Intrinsic Value Estimate

Dec 09
HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 26% Below Their Intrinsic Value Estimate

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Oct 10
Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

Is There An Opportunity With HealthEquity, Inc.'s (NASDAQ:HQY) 36% Undervaluation?

Sep 05
Is There An Opportunity With HealthEquity, Inc.'s (NASDAQ:HQY) 36% Undervaluation?

Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

Aug 09
Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?

CEO Compensation Analysis

How has Jon Kessler's remuneration changed compared to HealthEquity's earnings?
DateTotal CompensationSalaryCompany Earnings
Jan 31 2024n/an/a

US$56m

Oct 31 2023n/an/a

US$29m

Jul 31 2023n/an/a

US$13m

Apr 30 2023n/an/a

-US$8m

Jan 31 2023US$13mUS$700k

-US$26m

Oct 31 2022n/an/a

-US$59m

Jul 31 2022n/an/a

-US$62m

Apr 30 2022n/an/a

-US$55m

Jan 31 2022US$10mUS$700k

-US$44m

Oct 31 2021n/an/a

-US$6m

Jul 31 2021n/an/a

US$723k

Apr 30 2021n/an/a

US$4m

Jan 31 2021US$9mUS$667k

US$9m

Oct 31 2020n/an/a

US$3m

Jul 31 2020n/an/a

-US$20m

Apr 30 2020n/an/a

-US$332k

Jan 31 2020US$5mUS$500k

US$40m

Oct 31 2019n/an/a

US$53m

Jul 31 2019n/an/a

US$90m

Apr 30 2019n/an/a

US$93m

Jan 31 2019US$5mUS$483k

US$74m

Oct 31 2018n/an/a

US$67m

Jul 31 2018n/an/a

US$61m

Apr 30 2018n/an/a

US$56m

Jan 31 2018US$4mUS$400k

US$47m

Compensation vs Market: Jon's total compensation ($USD13.40M) is above average for companies of similar size in the US market ($USD8.45M).

Compensation vs Earnings: Jon's compensation has been consistent with company performance over the past year.


CEO

Jon Kessler (55 yo)

10.3yrs

Tenure

US$13,400,167

Compensation

Mr. Jon Kessler is a Member of the Board of Managers at HealthEquity Advisors, LLC. He has been the Chief Executive Officer and President of HealthEquity, Inc. since February 2014. Mr. Kessler founded Wage...


Leadership Team

NamePositionTenureCompensationOwnership
Jon Kessler
President10.3yrsUS$13.40m0.45%
$ 31.2m
Stephen Neeleman
Founder & Vice Chairman21.5yrsUS$2.79m0.96%
$ 65.6m
Elimelech Rosner
Executive VP & CTO2.2yrsUS$12.51m0.011%
$ 753.1k
James Lucania
CFO & Executive VPless than a yearno datano data
Angelique Hill
Executive Vice President of Operations6.1yrsno datano data
Richard Putnam
Vice President of Investor Relationsno datano datano data
Delano Ladd
Executive VP7.7yrsUS$1.53m0.043%
$ 3.0m
Steve Lindsay
Executive Vice President of Sales & Relationship Management2.8yrsno datano data
Brad Bennion
Senior Vice President of Corporate Development7.1yrsno datano data
Tia Padia
Executive VP & Chief Marketing Officer2.3yrsno datano data
Cheryl King
Executive VP & Chief People Officer1.1yrsno datano data
Kamesh Tumsi
Senior VP & Head of Product1.5yrsno datano data

2.8yrs

Average Tenure

54.5yo

Average Age

Experienced Management: HQY's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jon Kessler
President15.2yrsUS$13.40m0.45%
$ 31.2m
Stephen Neeleman
Founder & Vice Chairman21.5yrsUS$2.79m0.96%
$ 65.6m
Adrian Dillon
Independent Director7.7yrsUS$375.50k0.059%
$ 4.0m
Robert Selander
Independent Non-Executive Chairman8.7yrsUS$440.50k0.049%
$ 3.4m
Paul Black
Independent Director1.7yrsUS$191.81k0.00071%
$ 48.8k
Evelyn Dilsaver
Independent Director9.8yrsUS$363.00k0.034%
$ 2.3m
Frank Corvino
Independent Director9.8yrsUS$350.50k0.0048%
$ 329.1k
Stuart Parker
Independent Director3.4yrsUS$343.00k0.037%
$ 2.6m
Gayle Wellborn
Independent Director6.8yrsUS$363.00k0.014%
$ 958.5k
Debra McCowan
Independent Director6.1yrsUS$353.00k0.0082%
$ 564.1k
Rajesh Natarajan
Independent Director2yrsUS$278.11k0.0057%
$ 395.1k

7.7yrs

Average Tenure

62yo

Average Age

Experienced Board: HQY's board of directors are considered experienced (7.7 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.